TORONTO--(CardioComm Solutions, Inc. (TSX-V: EKG) announced today the recent signing of an agreement with Monebo Technologies, Inc. to develop a real-time ECG arrhythmia ‘triage’ solution. The software solution will work in line with CardioComm’s proprietary ECG acquisition and management software called GEMS™ (Global ECG Management Software), to properly risk stratify ECG recordings received from patients undergoing remote telemedicine-based cardiac monitoring.)--
“We’re excited to be working with CardioComm Solutions, a recognized leader in ECG management software”
The GEMS Triage software will allow medical providers in the hospital, clinic-based ECG monitoring centers, and busy medical call centers to properly assign resources to manage incoming ECG transmissions. The triaging functionality will thereby increase their efficiency of processing ECGs for reading and interpretation. Incoming ECGs will be ‘triaged’ or prioritized so the most important files are read first.
The new GEMS™ Triage will be used in association with CardioComm Solutions’ device-agnostic GEMS™ software, supporting qualified mobile ECG resting 12-lead telemetry devices and cardiac event recorders. CardioComm’s GEM product focus is on ECG signal retrieval via telephone, internet or cellular communications protocols, ECG interrogation and reporting, and archiving. Monebo’s technology will analyze the ECG data files as they are received and monitored for triaging, and provide rhythm interpretation.
“We’re excited to be working with CardioComm Solutions, a recognized leader in ECG management software,” said Patrick Kothe, Vice President and Chief Marketing Officer of Monebo. “We believe this joint effort will benefit clinicians and IDTFs (independent diagnostic testing facilities), and enhance the efficiency of their operations.”
Etienne Grima, CardioComm Solutions CEO, added that “Prioritizing ECG flow and reading has been a universal problem for commercial and high-volume, real-time ECG services and wireless transmission centers. Someone typically has to open each ECG file to review and flag the most urgent files for immediate interpretation and response. Large numbers of ‘normal’ or noisy ECG files are usually seen and, if flagged as less urgent by the triaging module, will allow services to focus resources on critical issues. Our joint solution will help automate the review and identification of all ECG files, and save on physician and attendant time and labor.”
The joint agreement provides CardioComm perpetual, non-exclusive worldwide distribution rights. GEMS Triage will be available to customers operating GEMS, GEMS Auto Attendant (telephony-based), GEMS Air (wireless-based), and soon-to-be-available GEMS M-Air (wireless MTC-based) products.
About CardioComm Solutions, Inc.
CardioComm’s patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB and FDA approved, and HIPAA compliant.
CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.
About Monebo Technologies
Monebo Technologies, Inc. is a private company based in Austin, Texas, dedicated to developing technology to monitor and interpret the electrical activity of the heart. The company is focused on providing solutions to allow patients and physicians to manage and reduce problems associated with cardiac disease, and have developed technology for ambulatory cardiac monitoring, home care, and pharmaceutical cardiac safety trials.
Monebo’s proprietary digital signal processing algorithms, highly developed sensor technology, and wireless communication capabilities provide accurate real-time monitoring information, with increased patient mobility.